get a key
steadybase-$ person Kevin Tansley
nameKevin Tansley
roleCFO
company Trinity Biotech plc TRIB
linkedin none on file
contactnot published
filingsnone on file
quotes
In response to the expected severe decline in revenues at the time, we implemented a series of measures aimed at significantly reducing or eliminating all discretionary expenditure. This included lower T&E and sales and marketing costs, for example, trade show costs.

Nov 17, 2020 / CFO / receipt, needs a key / Kevin Tansley, CFO | earnings call 2020-11-17 | transcript fc4ed100-2f6d-403c-8cef-d949581752af | chars 3620-3887 | segment 3

steadybase-$